Normal Immunoglobulin (Human) 16%, solution for subcutaneous administration.

Similar documents
EVOGAM. Information for patients Evogam NZ Patient Brochure Update FA3

EVOGAM. Information for patients Evogam 2014 NZ Patient Brochure Update v11

Human Normal Immunoglobulin 20% (20 g per 100 ml), solution for subcutaneous administration.

Before you are given Privigen

How Berinert works. Before you are given. Berinert. When you must not have it

What Biostate is used for

Gammanorm, 165 mg/ml, solution for injection Human normal immunoglobulin

Human coagulation factor VIII (FVIII) and human von Willebrand factor (VWF) complex, powder for injection. are essential for normal blood clotting.

STEP-BY-STEP GUIDE TO SELF-INFUSION. Subcutaneous Administration of GAMMAGARD LIQUID

Normal Immunoglobulin (Human), 10% for Intravenous or Subcutaneous Administration

PATIENT / USER INFORMATION LEAFLET. Cinryze 500 Units powder and solvent for solution for injection C1 inhibitor (human)

Prothrombinex -HT Human prothrombin complex, freeze-dried.

GAMUNEX. If you have any concerns about receiving this medicine, ask your doctor or pharmacist.

CONSUMER MEDICINE INFORMATION (CMI) OCTAGAM 10% [100 mg/ml]

FIRAZYR Icatibant acetate

D-Gam 250 micrograms/ml. Solution for injection. human anti-d immunoglobulin

Package leaflet: Information for the user. Cuvitru 200 mg/ml solution for subcutaneous injection Human normal immunoglobulin

What Neulasta is used for

Perjeta Contains the active ingredient pertuzumab (rch)

Package leaflet: Information for the user

Package Leaflet: Information for the User

SCIG INFUSIONS A PRACTICAL GUIDE FOR PATIENTS

IMPORTANT: PLEASE READ

Package leaflet: Information for the user

Before you are given CYRAMZA. When you must not be given it

IMPORTANT: PLEASE READ

Patient Information. EGRIFTA (eh-grif-tuh) (tesamorelin for injection) for subcutaneous use

AIMOVIG TM solution for injection in pre-filled pen erenumab Consumer Medicine Information

28 November 2008 CMI for NEUPOGEN Page 1 of 8

ZOSTAVAX Zoster Virus Vaccine Live (Oka/Merck), Refrigerator Stable.

Before you use NovoThirteen. When NovoThirteen should not be used

AIMOVIG solution for injection in pre-filled pen

DALACIN C PHOSPHATE Injection Clindamycin phosphate

Bicillin L-A Benzathine benzylpenicillin tetrahydrate

JvD/PL/ PACKAGE LEAFLET

Copaxone 20 mg/ml glatiramer acetate

RELISTOR. Methylnaltrexone bromide, Subcutaneous solution for injection. Consumer Medicine Information

DUKORAL. Oral inactivated cholera and ETEC vaccine. Consumer Medicine Information. It does not take the place of talking to your doctor or pharmacist.

Copaxone 40 mg/ml glatiramer acetate

INFORMATION FOR THE CONSUMER

Neulasta pegfilgrastim (rbe) Consumer Medicine Information

This leaflet answers some common questions about HERCEPTIN SC. It does not contain all the available information.

METALYSE Tenecteplase

ALLMERCAP. Consumer Medicine Information (CMI) What is in this leaflet. What ALLMERCAP is used for. Before you take it

Before you use it. When you must not use it

FUZEON enfuviride WHAT IS IN THIS LEAFLET BEFORE YOU USE FUZEON WHAT FUZEON IS USED FOR. When you must not use it. Use in children

Mycamine Micafungin (as sodium)

HEALTHCARE SUPPLIES SPECIALISTS. Product information. amaproducts.com.au HEALTHCARE SUPPLIES SPECIALISTS

Aranesp darbepoetin alfa

Before you take. Tell your doctor if you have any of the conditions mentioned below or if you have ever experienced any of these conditions.

Eloxatin Oxaliplatin concentrated solution for injection

CIPROXIN HC Ear Drops

MERIEUX INACTIVATED RABIES VACCINE (MIRV) Rabies Vaccine

NEXIUM INTRAVENOUS esomeprazole sodium

ZADITEN Eye Drops 1.0%

1 Before You Begin. Injection Instructions. Safety Tips. Disposing of Used Syringes, Needles, and Supplies. Having Someone Help You With Injections

TYPHIM Vi. Purified polysaccharide capsule of Salmonella typhi (Ty 2 strain) Consumer Medicine Information

GARDASIL 9 [Human Papillomavirus 9-valent Vaccine, Recombinant] Consumer Medicine Information

Nivestim Filgrastim [rbe] (fil-gras-tim)

A patient guide to administration of subcutaneous immunoglobulin replacement therapy - using manual push technique

All medicines have risks and benefits. Your doctor has weighed the risks of you being given Mabthera SC against the benefits expected for you.

How Entecavir GH Works

MERIEUX INACTIVATED RABIES VACCINE (MIRV)

This leaflet answers some common questions about PNEUMOVAX 23 (pronounced new-mo-vax). It does not contain all the available information.

paracetamol Please read this leaflet carefully before you are given Paracetamol BNM.

If you have any concerns about using this medicine, ask your doctor or pharmacist.

Instructional Guide RECONSTITUTION OF IDELVION USING THE MIX2VIAL TRANSFER SET

Glatopa is prescription medicine used for the treatment of people with relapsing forms of multiple sclerosis (MS).

TEVAGRASTIM filgrastim (rbe)

Oxytocin APOTEX Solution for Injection Contains the active ingredient synthetic oxytocin

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the user. HEPATECT CP 50 IU/ml solution for infusion. Human hepatitis B immunoglobulin for intravenous administration

เอกสารกาก บยาภาษาอ งกฤษ. AVAXIM 160 U Suspension for injection in a prefilled syringe Hepatitis A vaccine (inactivated, adsorbed)

TEVAGRASTIM. What is in this leaflet. What TEVAGRASTIM is used for. filgrastim (rbe) Consumer Medicine Information. How it works

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. AIM-oh-vig Pr AIMOVIG (erenumab injection)

Menomune. Meningococcal Polysaccharide Vaccine, Groups A, C, Y and W-135 Combined. Consumer Medicine Information

Pemetrexed APOTEX Powder for Injection Contains the active ingredient pemetrexed (as disodium)

Some general information on hepatitis A infection is given at the end of this leaflet.

NeisVac-C Meningococcal group C polysaccharide conjugate vaccine (tetanus toxoid protein conjugate)

IMOJEV Japanese encephalitis vaccine (live, attenuated)

SOMATULINE AUTOGEL. What is in this leaflet? 60, 90 AND 120 mg. Lanreotide CONSUMER MEDICINE INFORMATION

SOMATULINE AUTOGEL 60, 90 AND 120 mg

Aranesp darbepoetin alfa Consumer Medicine Information (CMI)

How to Use ENBREL : Vial Adapter Method

COMPANY CORE PACKAGE INSERT CCPI (PI/CORE/ENGLISH)

Package leaflet: Information for the user. GlucaGen HypoKit 1 mg Powder and solvent for solution for injection Glucagon

APO-Ondansetron Contains the active ingredient, ondansetron (as hydrochloride dihydrate)

Canesten Clotrimazole Thrush Treatment Once Cream

A step-by-step preparation guide

contains the active ingredient tocilizumab (rch) It does not contain all the available information.

Instructions for Use HEMLIBRA (hem-lee-bruh) (emicizumab-kxwh) injection, for subcutaneous use

APO-Olopatadine Eye Drops Contains the active ingredient olopatadine (as olopatadine hydrochloride)

VIVAXIM. Salmonella typhi Vi polysaccharide and inactivated hepatitis A virus antigen vaccine. Consumer Medicine Information

Aranesp darbepoetin alfa Consumer Medicine Information (CMI)

Package leaflet: Information for the user

belimumab (rmc) 120 mg and 400 mg powder Please read this leaflet carefully before you are given BENLYSTA.

INSTRUCTIONS FOR PREPARING AND GIVING AN INJECTION OF ENBREL POWDER

VIVAXIM Salmonella typhi Vi polysaccharide and inactivated hepatitis A virus antigen vaccine

Transcription:

Normal Immunoglobulin (Human) 16%, solution for subcutaneous administration. Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about. It does not contain all the available information. If you require further information about this medicine or your treatment, have any questions, or are not sure about something in this leaflet, consult your doctor. All medicines have benefits and risks. Your doctor has weighed the benefits that will have for you against the possible risks. If you have any concerns about taking this medicine, ask your doctor. Follow your doctor's advice even if it is different from what this leaflet says. Keep this leaflet with the medicine. You may need to read it again. What is used for Your medicine is, a solution for subcutaneous infusion. contains human immunoglobulins and is prepared from human blood collected by the Australian Red Cross Blood Service. Immunoglobulins are also called antibodies and are a type of protein found in the blood. Immunoglobulins are produced by your body's immune system to fight infections caused by bacteria and viruses. If you do not have enough antibodies you may not be able to fight off diseases. can be used as antibody replacement therapy, to correct this lack of antibodies. Your doctor may have prescribed for another reason. Ask your doctor if you have any questions about why it has been prescribed for you. Before you receive When you must not have it Do not have if you are allergic to: human immunoglobulin products glycine. If you are not sure whether you should be given this medicine talk to your doctor. Before you are given it Tell your doctor if you: are pregnant or breast-feeding have had any vaccination within the last two weeks are allergic to any medicine or food have IgA deficiency have a history of heart, or blood vessel disease, or blood clots, have thick blood, have been immobile for some time. Also tell the doctor what medicine you are using as some medicines, such as those that contain the hormone oestrogen (for example, birth control pills), may increase your risk of developing a blood clot. have blood group A, B or AB have any other medical conditions. If you have not told your doctor about any of the above, tell them before you are given. Your doctor can discuss with you the risks and benefits involved with using this medicine. About blood products When medicines are made from human blood or plasma, processes are used to prevent infections being passed from the blood/plasma donor to the person receiving the medicine. These processes include careful selection of the people who donate blood and plasma to make sure that those who might be carrying infections are excluded. In addition each donation and pools of donations are tested for indicators of virus or virus infection(s). Manufacturers of these medicines also include steps in the processing of blood or plasma that inactivate or remove viruses. Despite these processes, when medicines are prepared from human blood or plasma, the possibility of passing on an infection cannot be totally ruled out. Unknown or new viruses or other types of infection could also be passed on. The measures taken in the manufacture of this medicine are considered effective for enveloped viruses such as human immunodeficiency virus (HIV), hepatitis B virus, and hepatitis C virus, and for the non-enveloped viruses hepatitis A and B19 virus (B19V). There is reassuring clinical experience regarding the lack of hepatitis A or B19V infections

following treatment with immunoglobulin products. The antibodies which are in may also make an important contribution to limiting the possibility an infection could be passed on. Please discuss the risks and benefits of this product with your doctor. Taking other medicines Tell your doctor if you are taking any other medicines, including medicines that you buy without a prescription from your pharmacy, supermarket or health food shop. Some medicines may affect the way other medicines work. How is given Treatment should be started and supervised by a doctor. is administered as an injection or infusion subcutaneously (under the skin). If your doctor decides that you should receive at home, they will ensure you receive detailed instructions and training on how to use it. If you do not understand the instructions ask your doctor or health professional. How much is given Your doctor will determine the dose(s) of that you will receive, and when you need to have it. How to prepare it If your doctor considers that you should receive at home, the instructions below should be followed carefully. Step 1 Prepare and equipment a. Remove from the refrigerator and allow the vial of to reach room temperature prior to use, this will take approximately 20-60 minutes. b. Gather what you need for administration. This may include an infusion pump, administration tubing, subcutaneous needle or catheter set, Y-site connector, alcohol wipes, syringes, vial adapter, gauze or transparent dressing, tape, sharps disposal container, and treatment diary. c. Check vials. Carefully check the liquid in each vial, but do not shake it. is clear and colourless or pale-yellow or light-brown. If appears to be turbid or to contain sediment, it must not be used. If it is missing the protective cap, or is past its expiry date, it must not be used. d. Remove the protective cap from the vial and wipe the rubber stopper with an alcohol wipe. Step 2 Wash hands with soap and water and dry hands thoroughly with a clean towel. Step 3 Prepare vial adapter a. Remove the top cover of the vial adapter, leaving the adapter inside the blister pack. b. Place the vial on a flat surface. c. Place the vial adapter over the top of the vial, using the blister pack to handle the vial adapter. Press down firmly until the vial adapter snaps into place so that it pierces the rubber stopper (see Figure 1). d. Remove the outer package of the vial adapter and discard. Take care not to touch the exposed end of the device. Step 4 Prepare syringe Pull back the plunger of the syringe to fill the syringe with air. The amount of air should be the same as the amount of you will transfer from the vial (see Figure 2). Step 5 Connect to vial a. Attach the syringe to the vial adapter by twisting the syringe onto the connection. b. Push the plunger of the syringe down. This will inject the air from the syringe into the airspace of the vial (see Figure 3). Step 6 Withdraw from vial a. Turn the vial and syringe upside down whilst holding the plunger in, leaving the syringe and vial attached (see Figure 4).

To prime (fill) the tubing, connect the syringe filled with to the infusion tubing and gently push on the syringe plunger to fill the tubing with, until you see a drop of come out of the needle (see Figure 6). b. Release pressure on the plunger and pull back slowly to fill the syringe with. c. Detach the syringe from the vial adapter with a twist, leaving the vial adapter attached to the vial (see Figure 5). Repeat steps 3 to 6 if multiple vials are required to achieve the prescribed dose of. The same syringe may be used (to a maximum of 20 ml) but use a new vial adapter for each vial. Step 7 Prepare infusion tubing Step 8 Insert needle a. Select an appropriate infusion site. This may be the abdomen, thigh, upper arm, or side of the hip. The number and location of injection sites depends on the volume of the total dose. When a dose of more than 20 ml is given, it is advisable to give it in divided doses at different sites, which can be infused at the same time. b. Clean the injection site(s) as directed by your health care professional. c. Pinch together the skin around the injection site with two fingers and insert the needle under the skin (see Figure 7). d. Place sterile gauze and tape or a transparent dressing over the injection site. This will keep the needle from coming out (see Figure 8). Step 9 Check needle placement Make sure you are not injecting into a blood vessel. To test for this pull the plunger back gently (see Figure 9). If there is blood in the tubing, which would appear as red or pink fluid entering the tubing from the injection site, remove and discard the needle and tubing. Repeat steps beginning with step 7 using a new needle and tubing, and a new infusion site. If there is no blood in the tubing, continue to Step 10. Step 10 Start infusion Follow the instructions that you have been given by your doctor or nurse to start the infusion, and infuse at the rate you have been instructed. The recommended initial infusion rate is 10 ml/hr per injection site, with subsequent infusion rate increased as tolerated to a maximum of 20 ml/hr per site. Step 11 After the infusion a. Take off the dressing and take the needle out of the injection site, applying light pressure to the injection site. b. Throw away the single-use vial, along with the needle and tubing, in the sharps

container. Throw away dressing and tapes in the household waste. c. Record your treatment. Peel off the removable part of the label of the vial and put this label in your treatment diary or logbook. Document the date and time of your infusion, the amount of that you infused and the rate of infusion. If too much is given (overdose) The effects of an overdose of are not known. Please tell your doctor if you accidently use more than instructed. Things you must do Tell your doctor if you are planning on having a vaccination. may impair the effect of some virus vaccines such as measles, mumps, rubella and chicken pox for a period of at least six weeks, and up to three months. After receiving this medicine, a period of three months should be allowed before vaccination with some virus vaccines. In the case of measles vaccine, this effect may last for up to one year, so if you are going to receive a measles vaccine you should have your measles antibody status checked. Tell your doctor if you are about to have any blood tests. may interfere with the results of some tests, resulting in misleading results for some things. Inform other doctors, dentists, and pharmacists who treat you that you have been given this medicine. It is important for them to know if they are starting you on any other new medicines. Side effects All medicines can have side effects. Sometimes they are serious, most of the time they are not. You may need medical treatment if you experience some of the side effects. Do not be alarmed by the following lists of possible side effects. You may not experience any of them. If you have any questions, ask your doctor. Tell your doctor immediately or go to the Accident and Emergency Department at your nearest hospital if you notice any of the following symptoms: severe headache neck stiffness inability to stand bright light painful eye movements tingling, numbness or weakness on one side of the body pain/tenderness, swelling/discolouration of an arm or leg shortness of breath chest pain allergic or anaphylactic reaction, symptoms of which may include: - swelling of the lips, tongue or eyes - loss of consciousness - hives - difficulty in breathing. feeling very tired skin becoming yellow dark urine. Tell your doctor if you notice any of the following and they worry you: This list includes the more common side effects of. They are usually mild and often reduce over time: pain, itching, redness or swelling where the injection was given nausea or vomiting back and muscle pain abdominal pain paleness of skin diarrhoea headache fever or chills feeling faint (fall in blood pressure). abdominal pain pain in extremity fatigue joint pain. Other side effects not listed above may also occur in some patients. Tell your doctor if you notice any other effects. After having Storage Store at 2 C to 8 C. (Refrigerate. Do not freeze). Once removed from refrigeration, store below 25 C and use within 2 weeks. The product must not be returned to refrigeration. Leave vial in box until ready to use. Do not use after the expiry date. Keep it out of the reach and sight of children. Product description What it looks like is clear and colourless or pale-yellow or light-brown, and may be turbid in appearance. It is packaged in single use clear glass vials. Ingredients Each vial of contains a sterile solution comprising 16% plasma proteins of which at least 98% are immunoglobulins. does not contain any preservatives, so any unused portion should be discarded immediately. is packaged using latex free materials. is available in three different sizes, as are shown in the table:

Manufacturer is manufactured in Australia by: CSL Behring (Australia) Pty Ltd ABN 48 160 734 761 189-209 Camp Road Broadmeadows VIC 3047 Australia Distributor Australian Red Cross Blood Service Date of most recent amendment December 2015 Registered trademark of CSL Limited